The Efficacy of Minayo Iron-rich Nutritional Gummies on Female Anemia, Skin Condition and Qi-blood Deficiency Syndrome

Launched by HANGZHOU AGILE GROUPS NETWORK TECHNOLOGY CO., LTD. · Mar 5, 2025

Keywords

ClinConnect Summary

This clinical trial is studying the effects of Minayo Iron-rich Nutritional Gummies on women aged 18 to 45 who have mild anemia, skin conditions, and low energy due to Qi-blood deficiency syndrome. The goal is to see if these gummies can help improve their anemia, which is measured by checking levels of iron and hemoglobin in their blood. Participants will be randomly assigned to receive either the gummies or a placebo (a regular gummy that doesn’t have any active ingredients) for four weeks, with three visits to the study center in Shanghai to monitor progress and gather data.

To join the study, women must be between 18 and 45 years old and have mild anemia. They should not be taking iron supplements, certain medications, or have specific health conditions that could interfere with the trial. Participants will need to agree not to take any other drugs or supplements during the study, and they will be guided through all procedures with full explanations of what to expect. This trial aims to determine if these iron-rich gummies can effectively help improve their anemia and overall well-being.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Female subjects, aged 18 to 45;
• • 36 young women with mild anemia (hemoglobin value between 90-110 g/l) were recruited based on WHO diagnostic criteria for anemia. 10 of the subjects always have coffee and milk tea more than once per day;
• • Participants agree not to take any drugs, supplements, or other dairy products during the trial;
• • Participants agree not to take any other medications or supplements containing iron during the trial;
• • Antibiotics may be used unless medically required, but the type and dosage and days taken should be recorded;
• • Willing to refrain from participating in other interventional clinical studies during the trial period;
• • Fully understand the nature, purpose, benefits and possible risks and side effects of the study;
• • Willing to obey all test requirements and procedures;
• • Sign informed consent form.
• Exclusion Criteria:
• • Anemia due to organic conditions;
• • Subject who is in the treatment of gastrointestinal symptoms;
• • Lactose intolerance;
• • Subject who is currently presence of other organic diseases affecting intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, congenital megacolon, scleroderma, anorexia nervosa, etc.;
• • Controlling diet, exercising, or taking medications to control weight or affect appetite in the last 3 months;
• • Subject who has any of the following medical history or clinical findings that may affect the evaluation of the trial effect: significant gastrointestinal disorders, liver, kidney, endocrine, hematological, respiratory and cardiovascular diseases;
• • Abuse alcohol or other drugs, supplement or OTC drugs currently or in the past may cause bowel dysfunction or can affect test result evaluation;
• • Frequently use of medications that may affect gastrointestinal function or the immune system according to investigator's judgment;
• • Take laxatives or other substances that promote digestion 2 weeks before the trail start;
• • Subject who used drugs or supplements of iron agent 10 days before the beginning of the trial;
• • Pregnant or lactating women or those planning to become pregnant during the trial;
• • PI deems that subjects could not fully cooperate with trial arrangements.